Viewing Study NCT01757535

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:32 PM
Ignite Modification Date: 2026-02-20 @ 8:15 PM
Study NCT ID: NCT01757535
Status: COMPLETED
Last Update Posted: 2025-07-08
First Post: 2012-11-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
Sponsor: Celgene
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia, Myeloid, Acute View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Maintenance therapy View
None AML View
None Acute Myeloid Leukemia View
None Oral Azacitidine View
None Best supportive care View
None Complete remission View